NASDAQ:HEPA

Hepion Pharmaceuticals Earning Date

USA |NASDAQ |USD

HEPA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 16, 2021 (est) Sep 30, 2021 - $-0.10 $-0.69
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 16, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Hepion Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Nov 16, 2021 for the fiscal quarter ending Sep 30, 2021.

HEPA Earnings Date & History Chart

HEPA Earnings & Revenue Forecast

HEPA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.35 $-0.35 $-0.35
Dec 2022 1 $-0.36 $-0.36 $-0.36

HEPA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.36 $-0.36 $-0.31
Dec 2022 0 / 0 $-0.56 $-0.58 $-0.49

HEPA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Dec 2022 1 $0.00 $0.00 $0.00

HEPA Earnings Date & Revenue History

HEPA Earnings History

|
Show More
Show More

HEPA Revenue History

|
Show More
Show More

Hepion Pharmaceuticals Next Earnings Date & Report

HEPA Aug 2021 (FQ) Earnings Date & Report Preview

HEPA's next estimated earnings date (based on same quarter last year's report date) is Nov 16, 2021 for the fiscal quarter ending Sep 30, 2021.

Hepion Pharmaceuticals Previous Earnings Dates & Reports

HEPA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Hepion Pharmaceuticals's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

HEPA's earnings per share (EPS) was $-0.10.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -16.67%, and higher than the same period a year before (Jun 2020) by -82.76%.

Revenues were $0.00.

The company reported a net income of $-7.67M.

Free cash flow for the quarter was $-5.18M , compared to $-7.43M last quarter and $-3.12M a year before.

HEPA ended the quarter with $452.87K in total debt, a decrease of -34.19% compared to the previous quarter, and a decrease of -47.91% compared to the same quarter a year before.

HEPA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Hepion Pharmaceuticals's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

HEPA's earnings per share (EPS) was $-2.53, missing the consensus analysts forecast of $-1.62 by 56.17% , and higher than the previous year's EPS (Dec 2019) by -84.73%.

Revenues were $0.00.

The company reported a net income of $-20.35M.

Hepion Pharmaceuticals reported a free cash flow of $-16.25M for its fiscal year, compared to $-7.62M a year ago.

The company ended the fiscal year with $456.41K in total debt, a decrease of -43.47% compared to the previous year.